Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

1.

Varenicline-induced psychotic depressive episode in a patient with bipolar disorder.

Annagur BB, Bez Y.

Ther Adv Psychopharmacol. 2012 Feb;2(1):35-7. doi: 10.1177/2045125311430111.

PMID:
23983954
[PubMed]
Free PMC Article
2.

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.

Prochaska JJ, Hilton JF.

BMJ. 2012 May 4;344:e2856. doi: 10.1136/bmj.e2856. Review.

PMID:
22563098
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline.

Tranel D, McNutt A, Bechara A.

Cogn Behav Neurol. 2012 Mar;25(1):16-24. doi: 10.1097/WNN.0b013e3182492a9c.

PMID:
22330182
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis.

Leung LK, Patafio FM, Rosser WW.

BMC Clin Pharmacol. 2011 Sep 28;11:15. doi: 10.1186/1472-6904-11-15. Review.

PMID:
21955317
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Smoking cessation: an economic analysis and review of varenicline.

Faulkner MA.

Clinicoecon Outcomes Res. 2009;1:25-34. Epub 2009 Jun 24.

PMID:
21935304
[PubMed]
Free PMC Article
6.

The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.

Wildeboer-Andrud KM, Stevens KE.

Pharmacol Biochem Behav. 2011 Nov;100(1):17-24. doi: 10.1016/j.pbb.2011.07.001. Epub 2011 Jul 7.

PMID:
21763340
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.

Singh S, Loke YK, Spangler JG, Furberg CD.

CMAJ. 2011 Sep 6;183(12):1359-66. doi: 10.1503/cmaj.110218. Epub 2011 Jul 4. Review.

PMID:
21727225
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Using extended cognitive behavioral treatment and medication to treat dependent smokers.

Hall SM, Humfleet GL, Muñoz RF, Reus VI, Prochaska JJ, Robbins JA.

Am J Public Health. 2011 Dec;101(12):2349-56. doi: 10.2105/AJPH.2010.300084. Epub 2011 Jun 8.

PMID:
21653904
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Varenicline for tobacco dependence: panacea or plight?

Williams JM, Steinberg MB, Steinberg ML, Gandhi KK, Ulpe R, Foulds J.

Expert Opin Pharmacother. 2011 Aug;12(11):1799-812. doi: 10.1517/14656566.2011.587121. Epub 2011 Jun 6. Review.

PMID:
21644843
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Targeting nicotine addiction: the possibility of a therapeutic vaccine.

Escobar-Chávez JJ, Domínguez-Delgado CL, Rodríguez-Cruz IM.

Drug Des Devel Ther. 2011;5:211-24. doi: 10.2147/DDDT.S10033. Epub 2011 Apr 18. Review. Erratum in: Drug Des Devel Ther. 2011;5:487.

PMID:
21607018
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Adherence to varenicline in the COMPASS smoking cessation intervention trial.

Catz SL, Jack LM, McClure JB, Javitz HS, Deprey M, Zbikowski SM, McAfee T, Richards J, Swan GE.

Nicotine Tob Res. 2011 May;13(5):361-8. doi: 10.1093/ntr/ntr003. Epub 2011 Feb 24.

PMID:
21350041
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations.

Ebbert JO, Wyatt KD, Hays JT, Klee EW, Hurt RD.

Patient Prefer Adherence. 2010 Oct 5;4:355-62.

PMID:
21049087
[PubMed]
Free PMC Article
14.

Smoking outcome by psychiatric history after behavioral and varenicline treatment.

McClure JB, Swan GE, Catz SL, Jack L, Javitz H, McAfee T, Deprey M, Richards J, Zbikowski SM.

J Subst Abuse Treat. 2010 Jun;38(4):394-402. doi: 10.1016/j.jsat.2010.03.007. Epub 2010 Apr 2.

PMID:
20363092
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Partial nicotinic acetylcholine (alpha4beta2) agonists as promising new medications for smoking cessation.

Singh J, Budhiraja S.

Indian J Pharmacol. 2008 Oct;40(5):191-6. doi: 10.4103/0253-7613.44150.

PMID:
20040957
[PubMed]
Free PMC Article
16.

Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.

Ebbert JO, Wyatt KD, Zirakzadeh A, Burke MV, Hays J.

Int J Chron Obstruct Pulmon Dis. 2009;4:421-30. Epub 2009 Nov 29. Review.

PMID:
20037681
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Population pharmacokinetic analysis of varenicline in adult smokers.

Ravva P, Gastonguay MR, Tensfeldt TG, Faessel HM.

Br J Clin Pharmacol. 2009 Nov;68(5):669-81. doi: 10.1111/j.1365-2125.2009.03520.x.

PMID:
19916991
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.

Mills EJ, Wu P, Spurden D, Ebbert JO, Wilson K.

Harm Reduct J. 2009 Sep 18;6:25. doi: 10.1186/1477-7517-6-25.

PMID:
19761618
[PubMed]
Free PMC Article
19.

Real world study to evaluate the effectiveness of varenicline and cognitive-behavioural interventions for smoking cessation.

Ramon JM, Bruguera E.

Int J Environ Res Public Health. 2009 Apr;6(4):1530-8. doi: 10.3390/ijerph6041530. Epub 2009 Apr 21.

PMID:
19440532
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Extended treatment of older cigarette smokers.

Hall SM, Humfleet GL, Muñoz RF, Reus VI, Robbins JA, Prochaska JJ.

Addiction. 2009 Jun;104(6):1043-52. doi: 10.1111/j.1360-0443.2009.02548.x. Epub 2009 Apr 9. Erratum in: Addiction. 2011 Jun;106(6):1204.

PMID:
19392908
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk